期刊
CANCER CELL
卷 16, 期 6, 页码 510-520出版社
CELL PRESS
DOI: 10.1016/j.ccr.2009.10.013
关键词
-
资金
- National Cancer Institute [CA104898, CA115410, CA119414, CA119335, CA30199]
- Department of Defense [W81XWH-08-1-0727, W81XWH-08-BCRP-CIA]
Poor penetration of drugs into tumors is a major obstacle in tumor treatment. We describe a strategy for peptide-mediated delivery of compounds deep into the tumor parenchyma that uses a tumor-homing peptide, iRGD (CRGDK/RGPD/EC). Intravenously injected compounds coupled to iRGD bound to tumor vessels and spread into the extravascular tumor parenchyma, whereas conventional RGD peptides; only delivered the cargo to the blood vessels. iRGD homes to tumors through a three-step process: the RGD motif mediates binding to alpha v integrins on tumor endothelium and a proteolytic cleavage then exposes a binding motif for neuropilin-1, which mediates penetration into tissue and cells. Conjugation to iRGD significantly improved the sensitivity of tumor-imaging agents and enhanced the activity of an antitumor drug.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据